Skip to content

Author

Rui Li

We have 2 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Pathologic complete response after first-line tislelizumab, cetuximab, and dabrafenib in microsatellite-stable BRAF V600E-mutant metastatic colorectal cancer: a case report.

BRAF V600E-mutant metastatic colorectal cancer (mCRC) is characterized by aggressive disease behavior and limited responsiveness to conventional systemic therapy. Although BRAF/EGFR-targeted therapies have improved clinical outcomes, durable complete remission remains uncommon, particularly in microsatellite-stable (MS...

Rong Li, Yan-Ping Lin, Jiang-Yan Guo et al. · 0 citations
Open access Aug 2026

STARD3NL as a prognostic marker related to an immunosuppressive tumor microenvironment in hepatocellular carcinoma

It is indicated that STARD3NL may have value as a prognostic biomarker associated with an immunosuppressive tumor microenvironment and patients with increased STARD3NL expression had poorer survival and multivariable analysis supported STARD3NL as an independent risk factor.

Di Li, Zi-Yu Liu, Lihe Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.